Abstract:Worldwide, gastric cancer (GC) represents the fifth cancer for incidence, and the third as cause of death in developed countries. Indeed, it resulted in more than 780,000 deaths in 2018. Helicobacter pylori appears to be responsible for the majority of these cancers. On the basis of recent studies, and either alone or combined with additional etiological factors, H. pylori is considered a “type I carcinogen.” Over recent decades, new insights have been obtained into the strategies that have been adopted by H. pylori to survive the acidic conditions of the gastric environment, and to result in persistent infection, and dysregulation of host functions. The multistep processes involved in the development of GC are initiated by transition of the mucosa into chronic non-atrophic gastritis, which is primarily triggered by infection with H. pylori . This gastritis then progresses into atrophic gastritis and intestinal metaplasia, and then to dysplasia, and following Correa’s cascade, to adenocarcinoma. The use of antibiotics for eradication of H. pylori can reduce the incidence of precancerous lesions only in the early stages of gastric carcinogenesis. Here, we first survey the etiology and risk factors of GC, and then we analyze the mechanisms underlying tumorigenesis induced by H. pylori , focusing attention on virulence factor CagA, inflammation, oxidative stress, and ErbB2 receptor tyrosine kinase. Moreover, we investigate the relationships between H. pylori eradication therapy and other diseases, considering not only cardia (upper stomach) cancers and Barrett’s esophagus, but also asthma and allergies, through discussion of the “hygiene hypothesis. ” This hypothesis suggests that improved hygiene and antibiotic use in early life reduces microbial exposure, such that the immune response does not become primed, and individuals are not protected against atopic disorders, asthma, and autoimmune diseases. Finally, we overview recent advances to uncover the complex interplay between H. pylori and the gut microbiota during gastric carcinogenesis, as characterized by reduced bacterial diversity and increased microbial dysbiosis. Indeed, it is of particular importance to identify the bacterial taxa of the stomach that might predict the outcome of gastric disease through the stages of Correa’s cascade, to improve prevention and therapy of gastric carcinoma.

Anti-Helicobacter Pylori Infection in Gastric Cancer Prevention

Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges

Gastric Microbiota in Gastric Cancer and Precancerous Stages: Mechanisms of Carcinogenesis and Clinical Value

Role of the Gastric Microbiome in Gastric Cancer: from Carcinogenesis to Treatment

Helicobacter Pylori and Gastric Cancer: Clinical Aspects

Cost-Effectiveness Analysis of Helicobacter Pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

Progress of Study on the Eradication of Helicobacter Pylori Infection and Gastric Cancer

Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-Up

Helicobacter Pylori Infection Following Endoscopic Resection of Early Gastric Cancer

Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship

Helicobacter Pyloriinfection and Esophageal Cancer Risk: an Updated Meta-Analysis

H pylori Treatment and Gastric Cancer Risk Among Patients With High Genetic Risk

Eradication of gastric cancer is now both possible and practical

The Role of Helicobacter Pylori Infection in the Development of Gastric Cancer - Review of the Literature

Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?

Targeting Helicobacter pylori in gastric carcinogenesis

Helicobacter: Inflammation, immunology and vaccines

Epidemiology of gastric cancer in relation to diet and Helicobacter pylori infection

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Gastric Cancer Prevention by Community Eradication of Helicobacter Pylori: a Cluster-Randomized Controlled Trial

Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer